

Do your patients know what their migraine triggers are?
Migraine affects up to 15% of the UK population and around two thirds of sufferers are women. Migraine is believed to be caused by the release of a chemical called serotonin or 5HT into the bloodstream from its storage sites in the body, resulting in changes in the neurotransmitters and blood vessels in the brain. Exactly what causes this to happen, is still a subject for research and debate. However, certain factors have been identified which can trigger attacks in susceptible people:
Helping you to help your patients
Migraine Action aims to bridge the gap between the migraineur and the medical world by providing unbiased information on all aspects of migraine, its causes, diagnosis and treatment.
Here are just a few of the ways the Migraine Action can help your patients:
Click on the links above for further information
STOP PRESS!
Allergan are holding a National Launch Meeting for BOTOX® as a prophylactic treatment in chronic migraine.
Chronic migraine is a potentially disabling and impactful disorder, both for patients and society, but is often underdiagnosed and undertreated. BOTOX® is the first treatment specifically licensed and labelled for the prophylaxis of headaches in adults with chronic migraine.
This scientific meeting will include sessions on chronic migraine management, the data supporting use of BOTOX® as prophylaxis in chronic migraine and will address the practicalities of using BOTOX® in the clinic.
For further information about this event, please click here to download the agenda. To request a link to the online registration page, please email your name and hospital / clinic address to allerganmeetings@banks-sadler.co.uk